Global Constipation Treatment Market to Reach $27.5 Billion by 2030
The global market for Constipation Treatment estimated at US$17.3 Billion in the year 2022, is projected to reach a revised size of US$27.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. Laxatives, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chloride Channel Activators segment is readjusted to a revised 4.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at 9% CAGR
The Constipation Treatment market in the U.S. is estimated at US$4.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.Select Competitors (Total 41 Featured) -
- Abbott
- AbbVie`s Inc.
- Albireo Pharma, Inc.
- AstraZeneca
- Bausch Health Companies Inc.
- Bayer AG
- Cosmo Pharma
- Daewoong
- Ironwood Pharmaceuticals
- Janssen Pharmaceutical
- Mallinckrodt Plc
- Prestige Brands
- Renexxion
- Sanofi
- Shionogi
- Takeda Pharmaceutical Company Limited
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- AbbVie`s Inc.
- Albireo Pharma, Inc.
- AstraZeneca
- Bausch Health Companies Inc.
- Bayer AG
- Cosmo Pharma
- Daewoong
- Ironwood Pharmaceuticals
- Janssen Pharmaceutical
- Mallinckrodt Plc
- Prestige Brands
- Renexxion
- Sanofi
- Shionogi
- Takeda Pharmaceutical Company Limited
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 17.3 Billion |
Forecasted Market Value ( USD | $ 27.5 Billion |
Compound Annual Growth Rate | 6.0% |
Regions Covered | Global |